Ca2+/calmodulin-dependent protein kinase II--a target for sodium valproate?
Savina
T A
TA
Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, 3 Institutskaya Street, Pushchino, 142290, Moscow Region.
Balashova
O A
OA
Shchipakina
T G
TG
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology* / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects / Q000201:enzymology* / Q000503:physiopathology; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2 / Q000187:drug effects / Q000378:metabolism*; D004195:Disease Models, Animal; D004789:Enzyme Activation / Q000187:drug effects; D020195:Epilepsy, Reflex / Q000188:drug therapy / Q000201:enzymology*; D006624:Hippocampus / Q000187:drug effects / Q000201:enzymology / Q000503:physiopathology; D007245:Inferior Colliculi / Q000187:drug effects / Q000201:enzymology / Q000503:physiopathology; D008297:Male; D019579:Neocortex / Q000187:drug effects / Q000201:enzymology / Q000503:physiopathology; D051381:Rats; D011919:Rats, Inbred Strains; D014635:Valproic Acid / Q000494:pharmacology* / Q000627:therapeutic use
D000927:Anticonvulsants; D014635:Valproic Acid; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2